The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Prudo-Chlebosz Raymond

Reporting owner CIK 0001653262 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Prudo-Chlebosz RaymondPrudo-Chlebosz RaymondPrudo-Chlebosz Raymond · August 18, 2026 · Stock award · Stock Option (Right to Buy)Prudo-Chlebosz Raymond · August 18, 2026 · Stock award · Stock Option (Right to Buy)Prudo-Chlebosz Raymond · October 5, 2026 · Stock award · American Depositary Shares representing Ordinary SharesPrudo-Chlebosz Raymond · August 18, 2026 · Stock award · American Depositary Shares representing Ordinary SharesPrudo-Chlebosz Raymond · December 16, 2025 · Purchase · Pre-Funded Warrants to purchase ADRsPrudo-Chlebosz Raymond · December 16, 2025 · Purchase · Warrants to purchase ADRsPrudo-Chlebosz Raymond · December 16, 2025 · Purchase · Pre-Funded Warrants to purchase ADRsPrudo-Chlebosz Raymond · December 16, 2025 · Purchase · Warrants to purchase American Depositary Shares ("ADRs")Dec 16, 2025Oct 5, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

8 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Aug 18, 2026Akari Therapeutics PlcStock Option (Right to Buy)Prudo-Chlebosz RaymondStock award
Aug 18, 2026Akari Therapeutics PlcStock Option (Right to Buy)Prudo-Chlebosz RaymondStock award
Oct 5, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesPrudo-Chlebosz RaymondStock award
Aug 18, 2026Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesPrudo-Chlebosz RaymondStock award
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPrudo-Chlebosz RaymondPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsPrudo-Chlebosz RaymondPurchase
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPrudo-Chlebosz RaymondPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Prudo-Chlebosz RaymondPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardStock Option (Right to Buy)Derivative security · Code A15,0000Value: 0Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardStock Option (Right to Buy)Derivative security · Code A30,0000Value: 0Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A3,2407.899Value: 25,592.76Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsStock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A9,0727.899Value: 71,659.728Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P386,6610.4041 *Value: 156,249.7101Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P386,661Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P618,6580.4041 *Value: 249,999.6978Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P618,658Not reported *Value: Not reportedCurrency not specifiedView ↗